Early research (Phase 1)Study completedNCT02916095What this trial is testingKanitinib in Treating Patients With Advanced Solid TumorsWho this might be right forSolid Tumors Beijing Konruns Pharmaceutical Co., Ltd. 9
Early research (Phase 1)WithdrawnNCT06626256What this trial is testingSTIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWho this might be right forLocally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more City of Hope Medical Center
Early research (Phase 1)Active Not RecruitingNCT03589339What this trial is testingNBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 TherapyWho this might be right forRadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more Nanobiotix 145
Not applicableEnded earlyNCT05471271What this trial is testingIL-2 PET Imaging in Advanced Solid TumoursWho this might be right forMetastatic Solid Tumor University Medical Center Groningen 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07307053What this trial is testingRare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)Who this might be right forRare Malignant NeoplasmAdvanced Solid TumorsMetastatic Solid Tumors Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600
Early research (Phase 1)Ended earlyNCT04167137What this trial is testingSafety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult ParticipantsWho this might be right forMetastatic Solid NeoplasmLymphoma Synlogic 32
Testing effectiveness (Phase 2)UnknownNCT05268666What this trial is testingOrally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid TumorsWho this might be right forLocally Advanced Solid TumorMetastatic Solid Tumor Jubilant Therapeutics Inc. 126
Testing effectiveness (Phase 2)Looking for participantsNCT04116541What this trial is testingA Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.Who this might be right forMalignant Solid Tumor Centre Leon Berard 455
Early research (Phase 1)Study completedNCT00375245What this trial is testingRapamycin With Grapefruit Juice for Advanced MalignanciesWho this might be right forTumorsNeoplasm Metastasis University of Chicago 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT03599765What this trial is testingSystemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid TumorWho this might be right forOligometastatic Malignant Solid Neoplasm M.D. Anderson Cancer Center 380
Early research (Phase 1)Looking for participantsNCT06912152What this trial is testingMT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid TumorsWho this might be right forB7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors Zhejiang University 12
Early research (Phase 1)Looking for participantsNCT06418061What this trial is testingStudy of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid TumorsWho this might be right forUnresectableLocally Advanced or Metastatic Solid Tumors Innovent Biologics (Suzhou) Co. Ltd. 198
Not applicableStudy completedNCT01705548What this trial is testingHypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain MetastasisWho this might be right forMetastatic Malignant Neoplasm to BrainUnspecified Adult Solid Tumor, Protocol Specific Emory University 24
Not applicableUnknownNCT05426317What this trial is testingExploratory Interventional Study of Prognostic Serum Biomarkers of Cancer ProgressionWho this might be right forMelanomaNon Small Cell Lung CancerRenal Cancer University Hospital, Clermont-Ferrand 100
Early research (Phase 1)Active Not RecruitingNCT05311397What this trial is testingA166 in Patients With Advanced Solid Malignant TumorsWho this might be right forBreast Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Testing effectiveness (Phase 2)Looking for participantsNCT06244771What this trial is testingA Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid TumorsWho this might be right forAdvanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more Frontier Medicines Corporation 403
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299What this trial is testingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more M.D. Anderson Cancer Center 35
Not applicableStudy completedNCT00997529What this trial is testingMini Allo Stem Cell Transplantation for the Treatment of Solid TumorsWho this might be right forMetastatic Solid Tumor Beth Israel Deaconess Medical Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT05824975What this trial is testingEvaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)Who this might be right forAdvanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more GI Innovation, Inc. 358